Table 2.

Medication usage between inflamed and uninflamed patient groups.

	Thiopurine	Anti-TNF (infliximab or adalimumab)	Steroids	Exclusive enteral nutrition	Ustekinumab	Vedolizumab
CRP ≥ 5 (n = 58)	27 patients	6 patients	5 patients	7 patients	0 patients	0 patients
CRP < 5 (n = 96)	53 patients	26 patients	14 patients	3 patients	0 patients	0 patients
p value*	0.30	0.01	0.28	0.03	n/a	n/a

Significant values are in [bold].

Patient were frequently on multiple therapies. Twenty-seven patients were on no medications, or only nutritional therapy, at the time of plasma sampling.

*Calculated using a χ² test.